drugset / Trial / NCT00645294

Open Label Study of Pharmacokinetics and Safety of Dose of Adefovir Dipivoxil in Children and Adolescents With HBV

NCT00645294

Phase 1/2 Completed 47 enrolled Gilead Sciences
RandomizedCrossoverOpen-label

Summary

Open-label study of the pharmacokinetics of adefovir dipivoxil in children and adolescents infected with chronic hepatitis B.

Timeline

Start
2003-02
Primary completion
2003-08
Completion
2003-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Adefovir dipivoxil Small molecule 0.14 mg/kg Oral
Subject Adefovir dipivoxil Small molecule 0.3 mg/kg Oral
Subject Adefovir dipivoxil Small molecule 10 mg Oral